Unibest
← Back to patent-cliff list

CAS 115-11-7

2-methylprop-1-ene2-Methyl-1-propene

Codes: EFAV-032, Cilastatin Sodium-032

Application context (from source-drug indications)

HIV infectionEfavirenz/Lamivudine/Tenofovir Disoproxil FumarateHIV infectionEfavirenzCreutzfeldt-Jakob diseaseEfavirenzAlzheimer's diseaseEfavirenzPancreatic cancerEfavirenzProstate cancerEfavirenzNon-Hodgkin lymphomaEfavirenzInfectious diseaseCilastatin Sodium

Source drugs (routes using this intermediate)

DrugTierExpiry
Efavirenz/Lamivudine/Tenofovir Disoproxil FumarateTier C — Watch / trade-
EfavirenzTier B — Position early-
Cilastatin SodiumTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.